Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate

Details Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate

2007-01-16

2007-01-16

Aulakh, Charanjit S. (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S094000, C514S294000

Reexamination Certificate

active

10749932

ABSTRACT:
The invention relates to crystalline S-(−)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid L-arginine salt tetrahydrate, a process for its preparation and pharmaceutical formulations incorporating it as the active ingredient for use in treating microbial infections.

REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuewes et al.
patent: 3924042 (1975-12-01), Gerster et al.
patent: 3984403 (1976-10-01), Fujisawa et al.
patent: 3985882 (1976-10-01), Gerster et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4051247 (1977-09-01), Schuppan et al.
patent: 4382892 (1983-05-01), Hayakawa et al.
patent: 4399134 (1983-08-01), Ishikawa et al.
patent: 4404207 (1983-09-01), Stern et al.
patent: 4416884 (1983-11-01), Ishikawa et al.
patent: 4443447 (1984-04-01), Gerster et al.
patent: 4472406 (1984-09-01), Gerster et al.
patent: 4472407 (1984-09-01), Stern et al.
patent: 4535161 (1985-08-01), Hayakawa et al.
patent: 4552879 (1985-11-01), Ishikawa et al.
patent: 4563459 (1986-01-01), Groher et al.
patent: 4594347 (1986-06-01), Ishikawa et al.
patent: 4599418 (1986-07-01), Irikura et al.
patent: 4638067 (1987-01-01), Culbertson et al.
patent: 4642355 (1987-02-01), Nakamura et al.
patent: 4665079 (1987-05-01), Culbertson et al.
patent: 4777175 (1988-10-01), Culbertson et al.
patent: 4822801 (1989-04-01), Domagala et al.
patent: 4874764 (1989-10-01), Ueda et al.
patent: 4880806 (1989-11-01), Ueda et al.
patent: 4894458 (1990-01-01), Masuzawa et al.
patent: 4935420 (1990-06-01), Ueda et al.
patent: 4997943 (1991-03-01), Iwata et al.
patent: 5051509 (1991-09-01), Nagano et al.
patent: 5097032 (1992-03-01), Domagala et al.
patent: 5185337 (1993-02-01), Fujii et al.
patent: 5290934 (1994-03-01), Ueda et al.
patent: 5348961 (1994-09-01), Iwata et al.
patent: 5420140 (1995-05-01), Perrin
patent: 5436367 (1995-07-01), Iwata et al.
patent: 5607942 (1997-03-01), Petersen et al.
patent: 5639886 (1997-06-01), Zerbes et al.
patent: 5677316 (1997-10-01), Ao et al.
patent: 5859026 (1999-01-01), Ito et al.
patent: 5869661 (1999-02-01), Ochi et al.
patent: 5889009 (1999-03-01), Miyake et al.
patent: 6034100 (2000-03-01), Adachi et al.
patent: 6121285 (2000-09-01), Takemura et al.
patent: 6136806 (2000-10-01), Hittel
patent: 6184388 (2001-02-01), Takemura et al.
patent: 6329391 (2001-12-01), Ledoussal et al.
patent: 6514986 (2003-02-01), de Souza et al.
patent: 6664267 (2003-12-01), de Souza et al.
patent: 0241206 (1987-10-01), None
patent: 0287951 (1988-10-01), None
patent: 0300735 (1989-01-01), None
patent: 0304087 (1989-02-01), None
patent: 0230295 (1989-07-01), None
patent: 0342675 (1989-11-01), None
patent: 0541086 (1993-05-01), None
patent: 0572259 (1993-12-01), None
patent: 0394553 (1995-06-01), None
patent: 0908181 (1999-04-01), None
patent: 0919553 (1999-06-01), None
patent: 57081486 (1982-05-01), None
patent: 57176987 (1982-10-01), None
patent: 58090511 (1983-05-01), None
patent: 63192753 (1988-08-01), None
patent: 02131483 (1990-05-01), None
patent: 02188570 (1990-07-01), None
patent: 02188589 (1990-07-01), None
patent: 05339238 (1993-12-01), None
patent: 6-145167 (1994-05-01), None
patent: 9414794 (1994-07-01), None
patent: 9415938 (1994-07-01), None
patent: 9420105 (1994-09-01), None
patent: 9724128 (1997-07-01), None
patent: 9731000 (1997-08-01), None
patent: 9744034 (1997-11-01), None
patent: 98/58923 (1998-12-01), None
patent: 9858923 (1998-12-01), None
patent: 9914214 (1999-03-01), None
patent: 9926940 (1999-06-01), None
patent: 0018404 (2000-04-01), None
patent: 00/68229 (2000-11-01), None
patent: 0068229 (2000-11-01), None
patent: 01/85095 (2001-11-01), None
patent: 0185095 (2001-11-01), None
patent: 0185728 (2001-11-01), None
patent: 02/09758 (2002-02-01), None
patent: 0209758 (2002-02-01), None
patent: 03/099815 (2003-12-01), None
Asahina, Y. et al. “Recent advances in structure activity relationships in new quinolones”,Prog. Drug Res.(1992), 38: 57-106.
Japanese patent application 6-145167, dated May 24, 1994.
Cooper, C.S. et al. “Preparation and in Vitro and in Vivo Evaluation of Quinolones with Selective Activity against Gram Positive Organisms”,J. Med. Chem.1392-1398.
English abstract of WO 98/58923, dated Dec. 30, 1998.
English abstract of WO 94/14794, dated Jul. 7, 1994.
Chemical Abstracts 136:147733.
Chemical Abstracts 134:141378.
Chemical Abstracts 134:141377.
Chemical Abstracts 135: 300896.
Chemical Abstracts 130: 322834.
Chemical Abstracts 129:339430.
Chemical Abstracts 129:310840.
Chemical Abstracts 129:245024.
Chemical Abstracts 129: 239390.
Chemical Abstracts 127: 358825.
Chemical Abstracts 123: 164953.
Chemical Abstracts 124: 86783.
Chemical Abstracts 124: 170377.
Chemical Abstracts 124:343084.
Chemical Abstracts 127: 302924.
Chemical Abstracts 131: 153420.
Chemical Abstracts: 136:2738.
European Patent Specification 0394553 B1, dated Jun. 21, 1995.
Alsina J. et al. “Active Carbonate Resins for Solid-Phase Synthesis Through the Anchoring of a Hydroxyl Function. Synthesis of Cyclic and Alcohol Peptides”,Tetrahedron Letters, (1997), 38(5): 883-886.
Edwards W.B. et al. “Generally Applicable, Convenient Solid-Phase Synthesis and Receptor Affinities of Octreotide Analogs”,J. Med. Chem.,(1994), 37(22): 3749-3757.
Dhople, A.M. and M.A. Tbanez. “In vivosusceptibility of mycobacterium leprae to ofloxacin either singly or in combination with Rifampicin and Rifabutin”,Arzneimittel-Forschung,, (1994), 44(4): 563-565.
Haustein U.F. et al. “Topical quinolone nadifoloxacin (OPC-7251) in bacterial skin disease: clinical evaluation in a multicenter open trial and in vitro antimicrobiological susceptibility testing”,J. Dermatological Treatment, (1997), 8: 87-92.
Hashimoto, Koji et al. “A Practical Synthesis of (S)-(-)-Nadifloxacin: Novel Acid-Catalyzed Racemization of Tetrahydroquinaldine Derivative”,Chem. Pharm. Bull.,(1996), 44(4): 642-645.
Irish, D. et al. “Control of an outbreak of an epidemic methicillin-resistantStaphylococcus aureusalso resistant to mupirocin”,J. Hospital Infection, (1996), 39: 19-26.
Kido, M. et al. “Crystal Structures of Nadifloxacin Anhydride and its Hemihydrate”.Chem. Pharm. Bull.,(1994), 42(4):872-876.
Takahashi et al. “Reduction of in vitro Clastogenecity Induced by the Mixture of Optical Isomers of Nadifloxacin during Storage”,Arzneim.-Forsch./Drug Res.,(1995), 45(1): 195-197.
Sloan et al. “Definition and attainment of high purity of organic compounds”, Chapter 2, 179-182,Physics and Chemistry of the Organic Solid State,eds. D. Fox, Labes and Weissberer. Interscience Publishers, London. 1963.
Morita, S. et al. “An efficient synthesis of a key determinate towards (S)-(-)-Nadifloxacin”,Tetrahedron: Asymmetry,(1995), 6(1): 245-254.
Morita, S. et al. “Synthesis and Antibacterial Activity of the Metabolites of 9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid (OPC-7251)”,Chem. Pharm.Bull.,(1990), 38(7): 2027-2029.
Ishikawa, H. et al. “Studies on Antibacterial agents. I. Synthesis of Substituted 6,7-Dihydro-1-oxo-1H,5H-benzo[i,j]-quinolizine-2-carboxylic acids”,Chem. Pharm. Bul.,(1989), 37(8): 2103-2108.
English translation of Yamada, Hirao et al. “Evaluation of thein vitrodrug efficacy of Nadifloxacin Cream”,Iyakuhin Kenkyu,(2000), 31 (8): 519-524.
English abstract of Japanese patent 02131483, dated May 21, 1990.
English abstract of Japanese patent 02188589, dated Jul. 24, 1990.
English translation of Yamada, Hiroaki, et al. “Bioequivalency of 1% Nadifloxacin lotion and 1% of Nadifloxacin cream”,Iyakuhin Kenkyu,(2000), 31(8): 525-528.
Berge, Stephen M. et al. “Pharmaceutical Salts”,J. Pharmaceutical Sciences,(1977), 66(1): 1-19.
Abstract of Koike, M. et al.Iyakuhin Kenkyu,(1990),

Affiliated with

Also associated with

Rating

Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3801529